RxDoctor Payments Data

Lacey Fisher, APRN

Psychiatric/Mental Health · Fort Collins, CONPI 1306089214

Payments from drug & device makers

$2,015in general payments, 2019–2025

Across 18 payments — averaging $111.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$2K
  • Amgen$116
  • AbbVie$103
  • Sanofi$90
  • Merz Pharmaceuticals, LLC$78
  • Biogen$42
  • plus $16 from 1 others

What the payments were for

  • Travel & lodging$1,39969%
  • Food & beverage$61631%

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,015 in reported general payments places this provider in the 85th percentile of 873 psychiatric/mental health providers in Colorado.

See all psychiatric/mental health providers in Colorado

Medicare billing

Part B allowed, 2024
$25,263
Medicare patients
122
Services billed
329

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$138,830
Invega SustennaPaliperidone Palmitate29$106,719
VraylarCariprazine Hcl11$21,487
LatudaLurasidone Hcl13$20,286
LybalviOlanzapine/Samidorphan Malate11$18,710
ZyprexaOlanzapine12$14,730
Clozapine125$8,841
TrintellixVortioxetine Hydrobromide15$7,173
Lurasidone Hcl66$6,974
Ziprasidone Hcl63$4,940
Aripiprazole150$4,674
Olanzapine274$4,119
AmbienZolpidem Tartrate12$3,207
Divalproex Sodium ErDivalproex Sodium87$2,913
Fluvoxamine Maleate30$2,673

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$103$21,48711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 873 psychiatric/mental health providers in Colorado.

Other psychiatric/mental health in Fort Collins

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →